Forward Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Forward Pharmaceuticals Co., Ltd., explained in plain language.
-
New hope for advanced breast cancer? drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called FWD1802 combined with other treatments for people with ER-positive/HER2-negative breast cancer that has spread or cannot be removed by surgery. About 196 participants will join to find safe doses and see if the combinations shrink tumors. The go…
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:07 UTC
-
New hope for advanced breast cancer: experimental drug FWD1802 enters human trials
Disease control Recruiting nowThis study tests a new drug called FWD1802 in people with a specific type of advanced breast cancer (ER+/HER2-). The goal is to find a safe dose and see if it can shrink tumors. About 99 women with cancer that has spread or cannot be removed by surgery will take part.
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 12:01 UTC